BENGALURU, July 26 (Reuters) – GlaxoSmithKline Pharmaceuticals (GLAX.NS), the Indian unit of UK’s GSK plc (GSK.L), posted an 11% rise in first-quarter profit on Wednesday, buoyed by strong demand for its vaccines. The firm said consolidated profit for the quarter ended June 30 rose to 1.32 billion rupees ($16.10 million) …
Read More »